TickerFacts.

Sigyn Therapeutics, Inc. (SIGY): Operating Income

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

-$2.52M
Year ended 2024-12-31
-$1.88M
Trailing 12 months to 2025-09-30
2014-12-31: -$387.5K2015-12-31: -$2.25M2017-12-31: -$2.03M2018-12-31: -$1.00M2019-12-31: -$518.0K2020-12-31: -$916.4K2021-12-31: -$2.01M2022-12-31: -$2.15M2023-12-31: -$2.46M2024-12-31: -$2.52M-$2.52M
2014-12-31 Operating Income (USD) 2024-12-31
Period endedOperating IncomeChange YoYSource filing
2024-12-31-$2.52Mn/m2025-04-15, From 2024-01-01
2023-12-31-$2.46Mn/m2025-04-15, From 2023-01-01
2022-12-31-$2.15Mn/m2024-02-20, From 2022-01-01
2021-12-31-$2.01Mn/m2023-03-31, From 2021-01-01
2020-12-31-$916.4Kn/m2022-03-21, From 2020-01-01
2019-12-31-$518.0Kn/m2020-03-30, From 2019-01-01
2018-12-31-$1.00Mn/m2020-03-30, From 2018-01-01
2017-12-31-$2.03Mn/a2019-04-01, From 2017-01-01
No annual figure between 2015-12-31 and 2017-12-31.
2015-12-31-$2.25Mn/m2016-03-30, From 2015-01-01
2014-12-31-$387.5Kn/a2016-03-30, From 2014-01-01